AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.15
-0.35 (-3.33%)
At close: Nov 4, 2024, 4:00 PM
11.00
+0.85 (8.37%)
After-hours: Nov 4, 2024, 7:59 PM EST

Company Description

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States.

The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies.

The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AdaptHealth Corp.
AdaptHealth logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 10,700
CEO Suzanne Foster

Contact Details

Address:
220 West Germantown Pike, Suite 250
Plymouth Meeting, Pennsylvania 19462
United States
Phone 610 424 4515
Website adapthealth.com

Stock Details

Ticker Symbol AHCO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001725255
CUSIP Number 00653Q102
ISIN Number US00653Q1022
Employer ID 82-3677704
SIC Code 8082

Key Executives

Name Position
Suzanne M. Foster Chief Executive Officer and Director
Jason A. Clemens C.F.A. Chief Financial Officer
Albert A. Prast Chief Technology Officer
Shaw A. Rietkerk Chief Business Officer
Scott Barnhart Chief Operating Officer
Christie E. Archbold Chief Accounting Officer
Nalin Narayanam Chief Information Officer
Wendy Russalesi Chief Compliance Officer
Jonathan B. Bush General Counsel
Leila Vargas Executive Vice President of Sales and Marketing

Latest SEC Filings

Date Type Title
Nov 4, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Oct 30, 2024 8-K Current Report
Oct 23, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 22, 2024 8-K Current Report
Sep 30, 2024 8-K Current Report
Sep 20, 2024 144 Filing
Sep 18, 2024 144 Filing
Sep 16, 2024 144 Filing
Sep 16, 2024 8-K Current Report
Sep 12, 2024 144 Filing